David G. Brachman

Radiation Oncology

350 W Thomas Rd
Phoenix, AZ 85013

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Response to the "Letter to the editor with regards to 'A biologically effective dose-based framework for integrating LDR brachytherapy and EBRT in glioblastoma treatment' by Turner et al." from Dr. Christopher J. Tien and Dr. Zhe (Jay) Chen.

Response to the "Letter to the editor with regards to 'A biologically effective dose-based framework for integrating LDR brachytherapy and EBRT in glioblastoma treatment' by Turner et al." from Dr. Christopher J. Tien and Dr. Zhe (Jay) Chen.

Journal: Brachytherapy

Published: April 13, 2026

Local control and leptomeningeal disease after resection and GammaTile brachytherapy for newly diagnosed brain metastases: results from a prospective registry.

Local control and leptomeningeal disease after resection and GammaTile brachytherapy for newly diagnosed brain metastases: results from a prospective registry.

Journal: Journal of neuro-oncology

Published: December 29, 2025

A biologically effective dose-based framework for integrating LDR brachytherapy and EBRT in glioblastoma treatment.

A biologically effective dose-based framework for integrating LDR brachytherapy and EBRT in glioblastoma treatment.

Journal: Brachytherapy

Published: June 23, 2025

The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.

The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.

Journal: Journal of neuro-oncology

Published: October 10, 2023

Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial.

Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial.

Journal: Neuro-oncology

Published: November 02, 2022

Dosimetric Impacts of Source Migration, Radioisotope Type, and Decay with Permanent Implantable Collagen Tile Brachytherapy for Brain Tumors.

Dosimetric Impacts of Source Migration, Radioisotope Type, and Decay with Permanent Implantable Collagen Tile Brachytherapy for Brain Tumors.

Journal: Technology in cancer research & treatment

Published: June 17, 2022

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).

Journal: Neuro-oncology

Published: January 30, 2021

Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial.

Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial.

Journal: Cureus

Published: November 23, 2020

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 25, 2020

Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.

Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.

Journal: Journal of neurosurgery

Published: March 09, 2018

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database.

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database.

Journal: Neuro-oncology

Published: February 21, 2018

Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.

Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.

Journal: International journal of radiation oncology, biology, physics

Published: February 08, 2018

Showing 1-12 of 36

Last Updated: 09/26/2026